Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review

  • Authors:
    • Yohei Oguri
    • Haruhiko Cho
    • Ryouki Oohinata
    • Haruna Onoyama
    • Ryosuke Takada
    • Toru Motoi
  • View Affiliations

  • Published online on: October 5, 2018     https://doi.org/10.3892/mco.2018.1739
  • Pages: 661-665
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Primary gastric undifferentiated pleomorphic sarcoma (UPS) is a rare disease with insufficient long‑term follow‑up data. In the present study, a 70‑year‑old male complained of abdominal fullness and visited our hospital. Abdominal computed tomography revealed a large tumor in the upper part of the stomach, which was accompanied by smaller tumors in the small intestinal mesentery. An endoscopic ultrasound‑guided fine‑needle biopsy examination of the gastric tumor revealed features of pleomorphic sarcoma and high‑grade spindle‑shaped cells. Total gastrectomy was performed on the primary tumor, together with combined resection of the small intestine for the metastatic tumors. However, the tumor recurred in the mesentery of the sigmoid colon 6 months after the operation. A second operation was performed to resect the recurrent tumor. Since the second surgical procedure, the patient has remained free from recurrence for >7 years. Although the prognosis of abdominal UPS was considered to be poor, even after curative surgery, the present case experienced a long‑term survival of gastric UPS after undergoing surgical resection alone.

Introduction

Undifferentiated pleomorphic sarcoma (UPS), which was formerly known as malignant fibrous histiocytoma, is a high-grade sarcoma, which mainly arises from the soft tissue of the extremities and can appear at any age, but typically presents in the 5th-7th decades of life and exhibits a slight male predominance (1). Histopathologically, it is characterized by pleomorphic and spindle-shaped tumor cells and a storiform growth pattern; however, it lacks a definitive line of differentiation (2). To date, several cases of UPS that arose in the gastrointestinal tract have been reported, but these reports did not include long-term follow-up data. We report a case of UPS, in which the patient survived for more than 7 years after the surgical resection of the primary gastric tumor and metachronous metastases.

Case presentation

A 70-year-old male visited his primary care doctor, complaining of abdominal fullness and a palpable large mass in his lower abdomen. He was referred to our hospital for further investigation. He had a history of hypertension and had undergone resection of the right upper pulmonary lobe for tuberculosis 50 years ago. His blood examination findings only showed an elevated C-reactive protein level. An abdominal computed tomography (CT) scan revealed a 14-cm oval tumor in the wall of the stomach and two 10-cm tumors in the mesentery of the small intestine (Fig. 1). During magnetic resonance imaging (MRI), the tumor exhibited low signal intensity on T1-weighted images and high and diffuse signal intensity on T2-weighted images (Fig. 2). It also demonstrated a diffusional constraint on diffusion-weighted images. Upper gastrointestinal endoscopy showed a submucosal tumor, and endoscopic ultrasound (EUS) revealed a hypoechoic solid tumor, which was contiguous with the proper muscular layer (Fig. 3). An endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) was performed, and the specimen was found to contain atypical cells with pleomorphic or bizarre nuclei and a necrotic background, which was consistent with high-grade sarcoma. Atypical cells showed no definite differentiation by immunohistochemically, which were only positive for vimentin, and negative for α-smooth muscle actin, cytokeratin (AE1/AE3), epithelial membrane antigen, desmin, S-100 protein, c-Kit, CD34 and Melan-A. Based on these findings, we decided to perform total gastrectomy combined with resection of the accompanying tumors because it was considered that systemic therapy would not be effective. Twelve days after the EUS-FNB examination, the patient underwent total gastrectomy and combined resection of the small intestinal tumors. An intraoperative examination confirmed that the largest tumor originated from the anterior wall of the upper stomach and occupied the space between the stomach and the transverse colon, whereas the other tumors located in the ileal mesentery. There were no other masses in the abdominal cavity. Intraoperative peritoneal washing cytology was negative for tumor cells. As none of the tumors had invaded the adjacent organs, they were wholly resected via total gastrectomy and partial resection of the ileum. The gastric tumor was resected en bloc combined with D2 lymphadenectomy according to the Japanese Classification of Gastric Carcinoma guidelines (3).

Macroscopically, the resected gastric tumor was a well-demarcated solid grayish-white tumor, measuring 14×12×10 cm in size, which displayed extensive central necrosis and peripheral lobulation and protruded into the abdominal cavity (Fig. 4A and B). The other extra-gastric tumors measured 12.5×11×8.5 and 11.5×9.5×9 cm in size, respectively. Microscopically, the tumors were composed of atypical spindle-shaped and pleomorphic cells with large pleomorphic or bizarre nuclei (Fig. 4C). Mitotic figures, including abnormal mitoses, were frequently encountered (5–6/high-power field). The tumor displayed expansive growth without infiltrating into the adjacent tissue. No vascular invasion or regional lymph node metastasis was observed (0/44). Immunohistochemically, the atypical cells were positive for vimentin, but negative for cytokeratin (AE1/AE3 and CAM 5.2), epithelial membrane antigen, desmin, S-100 protein, c-Kit, CD34, mouse double minute 2 homolog (MDM2), cyclin-dependent kinase 4 (CDK4), and melan-A. The final pathological diagnosis was UPS of the stomach with peritoneal dissemination. The patient's postoperative course was uneventful; however, 6 months later, follow-up CT showed a tumor located in the ligament of the sigmoid colon, and so partial resection of the sigmoid colon was performed. The histological and immunohistochemical features of the resected tumor were almost the same as those of the primary tumor. Peritoneal washing cytology was positive for atypical cells. No adjuvant chemotherapy was administered because there is no standard chemotherapy regimen for abdominal UPS, UPS exhibits a low chemotherapy response rate, and chemotherapy can have side effects. Seven years after the surgery, the patient remains tumor-free.

Discussion

Gastric mesenchymal tumors are much rarer than gastric epithelial tumors. However, gastric mesenchymal tumors include both benign and malignant tumors. Among them, gastrointestinal stromal tumors (GIST) are the most common type of mesenchymal tumor, and most GIST exhibit benign behavior so there is little difficulty with their pathological diagnosis. Conversely, gastric sarcomas are reported to account for <1–3% of all gastric tumors, and they are difficult to diagnose based on their clinical and pathological findings (4). UPS is the commonest type of high-grade malignant sarcoma found in elderly people and most are asymptomatic but some case was reported fever as chief complaint because UPS producing activity cytokines as G-CSF (5). It is characterized as a pleomorphic sarcoma involving spindle-shaped cells, which is not very disease-specific, and does not exhibit marked cellular differentiation. Therefore, it is essentially diagnosed by exclusion, so it is necessary to carefully exclude other sarcomas whose histology overlap with that of UPS using electron microscopy and immunohistochemical techniques.

Regarding primary sarcoma of gastric origin, the main differential diagnoses for such cases include leiomyosarcoma and malignant peripheral nerve sheath tumors. However, in the present case these tumors were excluded because of the lack of neurogenic marker and smooth muscle marker expression (6,7). In addition, a rare type of malignant GIST, dedifferentiated GIST, in which a high-grade malignant sarcoma component is found in an ordinary GIST, was also considered; however, it was excluded due to the lack of a typical GIST component and the fact that the tumor was completely negative for c-kit (8). In this case, multiple tumors were detected in the abdominal cavity, including both simultaneous and metachronous tumors. Therefore, we also had to consider dedifferentiated liposarcoma (DLPS), which is a more common type of sarcoma of intra-abdominal/retroperitoneal origin that can involve the stomach and produce multiple tumor nodules. Although the histology of the dedifferentiated component of DLPS is indistinguishable from that of UPS, it typically contains a well-differentiated component, which exhibits marked adipocytic differentiation. Cytogenetically, DLPS is characterized by gene amplification of the 12q13-15 region, resulting in the overexpression of MDM2 and CDK4 (9). In the current case, DLPS was excluded because the tumor lacked adipocytic differentiation and did not overexpress MDM2 or CDK4.

Although there are no CT findings specific to UPS as far as we know, previous review of peritoneal sarcomatosis reported that peritoneal implants and mesenteric involvement were well-defined, and neither diffuse thickening nor calcifications (10). Also in our case, tumors were found to have well-defined shapes and central hypo-density areas as common characteristics of peritoneal sarcomas. The other report indicated the apparent diffusion coefficient (ADC) values caluculated from diffusion-weighted MRI was independent prognostic factor in gastric cancer (11). We might be able to apply ADC value of gastric UPS for prognostic indication.

With regard to the evaluation of the tumor's histological grade, the UPS was a large undifferentiated tumor containing frequent mitoses and extensive necrosis. According to the French Federation of Comprehensive Cancer Centers grading system for soft tissue sarcomas, it exhibited a tumor differentiation score of 3, a mitotic count score of 3, and a necrosis score of 2 and had an overall classification of grade 3, which is the highest grade (12). It is worth specifically mentioning that the patient in this case demonstrated an unexpectedly good prognosis in spite of the tumor's high-grade nature and the presence of intra-abdominal dissemination.

A review of the literature revealed 8 reported cases of primary gastric UPS (1318). Based on an analysis of the 9 reported cases of primary gastric UPS, including ours, the mean age of the patients was 68 years (range: 42–79 years), and the male-to-female ratio was 8:1 (Table I). The tumors measured between 3.5 and 12.0 cm in maximum diameter. As for the location of the sarcoma, it was located on the gastric body in 5 cases. There were no cases in which neoadjuvant or adjuvant chemotherapy was administered.

Table I.

Cases of primary gastric undifferentiated pleomorphic sarcoma.

Table I.

Cases of primary gastric undifferentiated pleomorphic sarcoma.

AuthorsAge (years)/sexTumor sizeLocationType of operationGross featuresChemotherapyPrognosis(Refs.)
Agaimy et al79/M8×7.5 cmUTotal gastrectomyPolypoid ulcerated and intramural, whitishNoneDied 2 weeks after op for pulmonary embolism(13)
Agaimy et al68/M12×9 cmM, GreDistal gastrectomyExtramural, gastric wall infiltrated, cystic areas, fleshy whitish-yellowNoneNo MTS, alive 6 months after op(13)
Wada et al78/M5.5×5 cmM, postPartial gastrectomyUlcerated, whitishNoneNo MTS, alive 2 years after op(14)
Wada et al77/M4×4 cmM, AntPartial gastrectomyUlcerated, yellowish-whiteNoneNo MTS, died 4 years after op for pneumonia(14)
Rathakrishnan et al51/MNDNDFeeding jejunostomy (inoperable)NDNoneDied a few weeks after op(15)
Wright et al42/M5 cmNDPartial gastrectomyPolypoid ulcerated, whitishNoneNo MTS, died 17 months after op(16)
Shibuya et al60/M4.5×4 cmM, AntTotal gastrectomyPolypoid, solid, whitishNoneNo MTS, died 3 months after op(17)
Morita et al60/F3.5×2.2 cmM, AntGatrectomySolid, yellowishNoneRecurrence 5 months after op, died 7 months after op(18)
Present case70/M14.0× 12.0 cmU, AntTotal gastrectomyCentral necrosis, solid, grayish-whiteNoneRecurrence 6 months after op, alive 7 years after op

[i] N/A, not available; M, male; F, female; U, upper third of the stomach; M, middle third of the stomach; Gre, greater curvature; Post, posterior wall; Ant, anterior wall; +, Lymph node dissection was performed; MTS, metastasis; op, operation.

This was a very significant case, in that we were able to control a high-grade primary gastric sarcoma using surgical resection alone. The administration of adjuvant or neoadjuvant chemotherapy has been widely adopted as a treatment strategy for soft tissue sarcomas; however, there is no standard chemotherapy regimen for abdominal UPS, and we decided not to administer chemotherapy in the present case based on the low response rate of such tumors and the potential complications of chemotherapy (19,20). According to the National Comprehensive Cancer Network soft tissue sarcoma guidelines, complete surgical resection with appropriate negative margins is the standard primary treatment for UPS (21). In spite of smaller surgical margin of gastric sarcoma than soft tissue sarcoma located at upper limbs or lower limbs, we were able to control this tumor via resection alone.

To the best of our knowledge, this is the first report about a case of primary gastric UPS involving positive peritoneal washing cytology results. Although the patient's good clinical course is difficult to explain based on the fact that the tumor was a high-grade sarcoma and peritoneal washing cytology produced positive results, we speculate that abdominal sarcomas like UPS do not have an invasive nature despite their high histological grade, which is unusual for this type of tumor. In the current case, continuous clinical observation for recurrence or metastasis will be necessary in case the tumor becomes more malignant.

In conclusion, this case deserves special mention, as it involved a high-grade sarcoma that was not treated with chemotherapy, and yet the patient exhibited a good prognosis. Clinicians should be aware that some sarcomas might follow a favorable course.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets obtained and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

YO, HC and TM analyzed patient data and wrote the manuscript. RO, HO and RT collected the data and critically revised the manuscript.

Ethics approval and consent to participate

This case report was approved by the institutional review board, and written informed consent was obtained from the patient.

Patient consent for publication

Written consent for publication was obtained from the patient.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

UPS

undifferentiated pleomorphic sarcoma

CT

computed tomography

MRI

magnetic resonance imaging

EUS

endoscopic ultrasound

FNB

fine-needle biopsy

MDM2

mouse double minute 2 homolog

CDK4

cyclin-dependent kinase 4

GIST

gastrointestinal stromal tumors

DLPS

dedifferentiated liposarcoma

References

1 

Fletcher CDM, Bridge JA, Hogendoorn P and Mertens F: WHO classification of tumours of soft tissue and bone. (4th). IARC Press. (Lyon). pp120–122. 2013.

2 

O'Brien JE and Stout AP: Malignant fibrous xanthomas. Cancer. 17:1445–1455. 1964. View Article : Google Scholar : PubMed/NCBI

3 

Sano T and Aiko T: New Japanese classifications and treatment guidelines for gastric cancer: Revision concepts and major revised points. Gastric Cancer. 14:97–100. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Soufi M, Errougani A and Chekkof RM: Primary gastric leiomyosarcoma in young revealed by a massive hematemesis. J Gastrointest Cancer. 40:69–72. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Kabashima A, Kimura K, Sanefuji K, Masunari S, Haraoka S and Maekawa S: A case of primary gastric undifferentiated high-grade pleomorphic sarcoma diagnosed with chief complaint of fever: A case report and literature review. Surg Case Rep. 3:412017. View Article : Google Scholar : PubMed/NCBI

6 

Welch JP: Smooth muscle tumors of the stomach. Am J Surg. 130:279–285. 1975. View Article : Google Scholar : PubMed/NCBI

7 

Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A and Maki RG: Malignant peripheral nerve sheath tumors. Oncologist. 19:193–201. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Virgilio E, Mercantini P, Tarantino G, Socciarelli F, Pilozzi E, Uccini S, Caterino S and Ziparo V: Gastrointestinal stromal tumors with de novo anaplastic dedifferentiation: Considerations on a little-known neoplastic metamorphosis. Int J Surg Pathol. 22:3852014. View Article : Google Scholar : PubMed/NCBI

9 

McGovern Y, Zhou CD and Jones RL: Systemic therapy in metastatic or unresectable well-differentiated/dedifferentiated liposarcoma. Front Oncol. 7:2922017. View Article : Google Scholar : PubMed/NCBI

10 

Villanueva A, Pérez C, Sabaté JM, Llauger J and Monill JM: CT manifestations of peritoneal leiomyosarcomatosis. Eur J Radiol. 17:166–169. 1993. View Article : Google Scholar : PubMed/NCBI

11 

Giganti F, Orsenigo E, Esposito A, Chiari D, Salerno A, Ambrosi A, Albarello L, Mazza E, Staudacher C, Del Maschio A, et al: Prognostic role of diffusion weighted MR imaging for resectable. Gastric cancer. Radiology. 276:444–452. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay JY, Coindre JM and Bui B: Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French Sarcoma Group database. Ann Oncol. 21:2436–2441. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Agaimy A, Gaumann A, Schroeder J, Dietmaier W, Hartmann A, Hofstaedter F, Wünsch PH and Mentzel T: Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: An approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation. Virchows Arch. 451:949–957. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Wada Y, Matsushita T, Sarumaru S, Ryo J, Isobe H, Satoh B, Kanaya S, Katayama T and Ohtoshi M: Malignant fibrous histiocytoma of the stomach: Report of two cases. Surg Today. 28:296–300. 1998. View Article : Google Scholar : PubMed/NCBI

15 

Rathakrishnan V, Arianayagam S and Kumar G: Primary malignant fibrous histiocytoma of the stomach: (A case report). Australas Radiol. 33:302–304. 1989. View Article : Google Scholar : PubMed/NCBI

16 

Wright JR Jr, Kyriakos M and DeSchryver-Kecsemeti K: Malignant fibrous histiocytoma of the stomach. A report and review of malignant fibrohistiocytic tumors of the alimentary tract. Arch Pathol Lab Med. 112:251–258. 1988.PubMed/NCBI

17 

Shibuya H, Azumi N, Onda Y and Abe F: Multiple primary malignant fibrous histiocytoma of the stomach and small intestine. Acta Pathol Jpn. 35:157–164. 1985.PubMed/NCBI

18 

Morita T, Kato T, Furukawa K and Itoh Y: A case report of malignant fibrous histiocytoma in the regions of stomach and gall bladder. J Jpn Soc Clin Cytol. 23:425–429. 1984. View Article : Google Scholar

19 

Pasquali S and Gronchi A: Neoadjuvant chemotherapy in soft tissue sarcomas: Latest evidence and clinical implications. Ther Adv Med Oncol. 9:415–429. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Guo J, Cui Q, Liu C, Sui J, Jiang N, Zhou J, Li D and Zeng Y: Clinical report on transarterial neoadjuvant chemotherapy of malignant fibrous histiocytoma in soft tissue. Clin Transl Oncol. 15:370–375. 2013. View Article : Google Scholar : PubMed/NCBI

21 

NCCN Guidelines for Patients. Soft Tissue Sarcoma. Version 1. 2014, https://www.nccn.org/patients/guidelines/sarcomaApril 12–2018

Related Articles

Journal Cover

December-2018
Volume 9 Issue 6

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Oguri Y, Cho H, Oohinata R, Onoyama H, Takada R and Motoi T: Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review. Mol Clin Oncol 9: 661-665, 2018
APA
Oguri, Y., Cho, H., Oohinata, R., Onoyama, H., Takada, R., & Motoi, T. (2018). Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review. Molecular and Clinical Oncology, 9, 661-665. https://doi.org/10.3892/mco.2018.1739
MLA
Oguri, Y., Cho, H., Oohinata, R., Onoyama, H., Takada, R., Motoi, T."Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review". Molecular and Clinical Oncology 9.6 (2018): 661-665.
Chicago
Oguri, Y., Cho, H., Oohinata, R., Onoyama, H., Takada, R., Motoi, T."Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: A case report and literature review". Molecular and Clinical Oncology 9, no. 6 (2018): 661-665. https://doi.org/10.3892/mco.2018.1739